NCT04059471View on ClinicalTrials.gov

Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine

PHASE4CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

November 11, 2019

Primary Completion Date

March 30, 2020

Study Completion Date

June 24, 2023

Conditions
Yellow Fever
Interventions
BIOLOGICAL

Yellow fever vaccine, Institut Pasteur

Full dose and 500IU/dose

Trial Locations (2)

254

KEMRI-Wellcome Trust Research Programme, Kilifi

Unknown

Epicentre, Mbarara., Mbarara

Sponsors

Collaborators (1)

Institut Pasteur
All Listed Sponsors
collaborator

KEMRI-Wellcome Trust Collaborative Research Program

OTHER

collaborator

Institut Pasteur

INDUSTRY

collaborator

MRC/UVRI and LSHTM Uganda Research Unit

OTHER

collaborator

Epicentre, Paris, France.

UNKNOWN

lead

University of Oxford

OTHER

NCT04059471 - Non- Inferiority Fractional-doses Trial for Yellow Fever Vaccine | Biotech Hunter | Biotech Hunter